Ovation Science Inc. (OVAT.CN)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 143.76 Thousand CAD | 1075.13% |
| 2022 | 12.23 Thousand CAD | 101.89% |
| 2021 | -647.56 Thousand CAD | -70.13% |
| 2020 | -380.62 Thousand CAD | -156.14% |
| 2019 | -148.59 Thousand CAD | 21.48% |
| 2018 | -189.23 Thousand CAD | -800.11% |
| 2017 | 27.03 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 244.49 Thousand CAD | 42.57% |
| 2024 Q1 | 171.48 Thousand CAD | 19.28% |
| 2023 Q1 | 38.97 Thousand CAD | 218.56% |
| 2023 FY | 143.76 Thousand CAD | 1075.13% |
| 2023 Q4 | 143.76 Thousand CAD | -19.33% |
| 2023 Q2 | 127.37 Thousand CAD | 226.84% |
| 2023 Q3 | 178.21 Thousand CAD | 39.91% |
| 2022 Q2 | -321.67 Thousand CAD | 35.22% |
| 2022 Q4 | 12.23 Thousand CAD | 108.22% |
| 2022 FY | 12.23 Thousand CAD | 101.89% |
| 2022 Q3 | -148.79 Thousand CAD | 53.75% |
| 2022 Q1 | -496.58 Thousand CAD | 23.32% |
| 2021 Q2 | -1.08 Million CAD | -387.52% |
| 2021 FY | -647.56 Thousand CAD | -70.13% |
| 2021 Q4 | -647.56 Thousand CAD | 25.58% |
| 2021 Q3 | -870.18 Thousand CAD | 19.91% |
| 2021 Q1 | -222.87 Thousand CAD | 41.45% |
| 2020 Q4 | -380.62 Thousand CAD | -307.89% |
| 2020 Q1 | 23.67 Thousand CAD | 115.93% |
| 2020 FY | -380.62 Thousand CAD | -156.14% |
| 2020 Q3 | -93.31 Thousand CAD | -359.05% |
| 2020 Q2 | 36.02 Thousand CAD | 52.15% |
| 2019 FY | -148.59 Thousand CAD | 21.48% |
| 2019 Q4 | -148.59 Thousand CAD | 83.56% |
| 2019 Q3 | -903.95 Thousand CAD | 25.47% |
| 2019 Q1 | -1.44 Million CAD | -661.25% |
| 2019 Q2 | -1.21 Million CAD | 15.81% |
| 2018 Q1 | 97.02 Thousand CAD | 0.0% |
| 2018 FY | -189.23 Thousand CAD | -800.11% |
| 2018 Q4 | -189.23 Thousand CAD | -182.27% |
| 2018 Q3 | 230.01 Thousand CAD | 24.97% |
| 2018 Q2 | 184.04 Thousand CAD | 89.69% |
| 2017 FY | 27.03 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | 82.598% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | -105.442% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 117.851% |
| The BC Bud Corporation | 225.15 Thousand CAD | 36.147% |
| BioNxt Solutions Inc. | 4.53 Million CAD | 96.827% |
| CordovaCann Corp. | 6.13 Million CAD | 97.655% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | 96.894% |
| Captor Capital Corp. | -5.41 Million CAD | 102.657% |
| City View Green Holdings Inc. | 1.49 Million CAD | 90.404% |
| 1CM Inc. | 3.31 Million CAD | 95.663% |
| Global Hemp Group Inc. | 3.55 Million CAD | 95.953% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 99.008% |
| IM Cannabis Corp. | 11.96 Million CAD | 98.799% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | 25.258% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 94.189% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 102.431% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 132.008% |
| Pharmadrug Inc. | 1.2 Million CAD | 88.086% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | 22.814% |
| RAMM Pharma Corp. | -4.71 Million CAD | 103.051% |
| RIV Capital Inc. | -101.38 Million CAD | 100.142% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | 118.019% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 99.945% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 99.31% |
| 1933 Industries Inc. | 16.47 Million CAD | 99.128% |
| Red Light Holland Corp. | -13.56 Million CAD | 101.06% |
| Top Strike Resources Corp. | 13.24 Million CAD | 98.915% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | 240.372% |
| Adastra Holdings Ltd. | 2.2 Million CAD | 93.478% |